Recombinant Human Growth Hormone (rhGH) therapy

Type: drug

Status: FDA Approved

Developer: Various (e.g., Genentech, Novo Nordisk)

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026